Diagnostic quality electrocardiogram from a HeartMate 3 supported patient using a smartphone-based recording device.
Emmanuel TasosJoao SequeiraPaul LincolnStephen J PettitSai Kiran BhagraPublished in: The International journal of artificial organs (2023)
Patients with implantable left ventricular assist devices (LVAD) are at risk of ventricular arrhythmias but these may be hemodynamically tolerated. An electrocardiogram (ECG) is essential to determine whether an LVAD-supported patient is experiencing a ventricular arrhythmia. Access to 12 lead ECG is predominantly in healthcare facilities. Implantable LVAD also cause significant electromagnetic interference leading to artefacts on ECG. We report a patient on Heartmate 3 LVAD with a diagnostic quality 6 lead ECG obtained with an AliveCor device during an episode of sustained palpitations. The AliveCor device may be used for remote identification of ventricular arrhythmias in LVAD patients.
Keyphrases
- left ventricular assist device
- left ventricular
- heart failure
- heart rate variability
- case report
- heart rate
- healthcare
- catheter ablation
- end stage renal disease
- ejection fraction
- chronic kidney disease
- prognostic factors
- newly diagnosed
- atrial fibrillation
- acute myocardial infarction
- quality improvement
- cardiac resynchronization therapy
- left atrial
- peritoneal dialysis
- patient reported outcomes
- congenital heart disease